Keywords: genzyme, 2nd-qtr, revenue, rises, usa, corp, reported
Genzyme's 2nd-qtr 2006 revenue rises 19%
Article | 24 July 2006
The USA's Genzyme Corp reported second-quarter 2006 revenue of $793.4 million, a 19% increase on the like, year-ago period, driven by growth across ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
